Stephen Yoder
Chief Executive Officer chez PIERIS PHARMACEUTICALS, INC.
Fortune : 1 098 $ au 31/03/2024
Profil
Stephen S.
Yoder is currently the President, Chief Executive Officer & Director at Pieris Pharmaceuticals, Inc. He is also the Co-Managing Director at Pieris Pharmaceuticals GmbH.
Previously, he served as the President & Chief Executive Officer at Marika, Inc. and as the President, Chief Executive Officer & Director at Pieris AG.
Prior to that, he worked as the General Counsel at MorphoSys AG from 1999 to 2010.
Mr. Yoder completed his undergraduate degree at Grove City College and his graduate degree at George Washington University Law School.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
19/04/2023 | 6 000 ( 0,01% ) | 1 098 $ | 31/03/2024 |
Postes actifs de Stephen Yoder
Sociétés | Poste | Début |
---|---|---|
PIERIS PHARMACEUTICALS, INC. | Chief Executive Officer | 01/01/2010 |
Pieris Pharmaceuticals GmbH
Pieris Pharmaceuticals GmbH BiotechnologyHealth Technology Part of Pieris Pharmaceuticals, Inc., Pieris Pharmaceuticals GmbH operates as a German biotechnology company. The private company is based in Hallbergmoos, Germany. The CEOs of the company are Hitto Kaufmann, Stephen S. Yoder. | Chief Executive Officer | - |
Anciens postes connus de Stephen Yoder
Sociétés | Poste | Fin |
---|---|---|
MORPHOSYS AG | General Counsel | - |
Marika, Inc.
Marika, Inc. Personnel ServicesCommercial Services Marika, Inc. is a development stage company which provides online job marketplace that connects people or companies in need to run errands or small tasks and the persons who wish to assist in running those errands or small tasks. Its services include: payment of utility bills, locating quality entertainment, picking up dry cleaning, grocery shopping, returning library books/videos, taking the car to the mechanic, party and event planning and all the other routine tasks. The company plan to conduct operations and market its services primary to North American and European markets. The company was founded on May 24, 2013 and is headquartered in Henderson, NV. | Chief Executive Officer | - |
Pieris AG
Pieris AG BiotechnologyHealth Technology Pieris AG develops and markets Anticalin-brand proteins. The firm specializes in the research and development of its Anticalin technology, with focus on deriving therapeutic proteins from human lipocalins. It focuses on solving pharmacological and pharmaceutical limitations of both protein- and non-protein-based drug platforms. It offers a pipeline of Anticalin therapeutics that has active and multi-program research and development collaborations with biopharmaceutical companies. The company was founded by Arne Skerra, Steffen Schlehuber, and Claus Schalper in 2001 and is headquartered in Freising, Germany. | Chief Executive Officer | - |
Formation de Stephen Yoder
Grove City College | Undergraduate Degree |
George Washington University Law School | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
MORPHOSYS AG | Health Technology |
PIERIS PHARMACEUTICALS, INC. | Health Technology |
Entreprise privées | 3 |
---|---|
Marika, Inc.
Marika, Inc. Personnel ServicesCommercial Services Marika, Inc. is a development stage company which provides online job marketplace that connects people or companies in need to run errands or small tasks and the persons who wish to assist in running those errands or small tasks. Its services include: payment of utility bills, locating quality entertainment, picking up dry cleaning, grocery shopping, returning library books/videos, taking the car to the mechanic, party and event planning and all the other routine tasks. The company plan to conduct operations and market its services primary to North American and European markets. The company was founded on May 24, 2013 and is headquartered in Henderson, NV. | Commercial Services |
Pieris AG
Pieris AG BiotechnologyHealth Technology Pieris AG develops and markets Anticalin-brand proteins. The firm specializes in the research and development of its Anticalin technology, with focus on deriving therapeutic proteins from human lipocalins. It focuses on solving pharmacological and pharmaceutical limitations of both protein- and non-protein-based drug platforms. It offers a pipeline of Anticalin therapeutics that has active and multi-program research and development collaborations with biopharmaceutical companies. The company was founded by Arne Skerra, Steffen Schlehuber, and Claus Schalper in 2001 and is headquartered in Freising, Germany. | Health Technology |
Pieris Pharmaceuticals GmbH
Pieris Pharmaceuticals GmbH BiotechnologyHealth Technology Part of Pieris Pharmaceuticals, Inc., Pieris Pharmaceuticals GmbH operates as a German biotechnology company. The private company is based in Hallbergmoos, Germany. The CEOs of the company are Hitto Kaufmann, Stephen S. Yoder. | Health Technology |